Rezolve AI Shares Surge On Microsoft Partnership Announcement: What You Need To Know
Rezolve AI Shares Surge On Microsoft Partnership Announcement: What You Need To Know
Rezolve AI Limited (NASDAQ:RZLV) shares are trading higher Thursday after the company announced a strategic partnership with Microsoft Corporation (NASDAQ:MSFT) to enhance global retail innovations using AI-powered commerce solutions.
Rezolve AI有限公司（納斯達克：RZLV）股價週四上漲，因公司宣佈與微軟-t（納斯達克：MSFT）達成戰略合作伙伴關係，利用人工智能驅動的商業解決方案增強全球零售創新。
What To Know: Rezolve AI and Microsoft have formed a collaboration to provide advanced digital engagement capabilities to retailers. Rezolve AI's Brain Suite—which includes Brain Commerce, Brain Checkout, and Brain Assistant—will be hosted on Microsoft Azure and available through the Azure Marketplace.
相關信息：Rezolve AI和微軟已合作提供先進的數字化參與能力給零售商。 Rezolve AI的Brain Suite——包括Brain Commerce、Brain Checkout和Brain Assistant——將託管在Microsoft Azure上，並通過Azure Marketplace提供。
The partnership includes extensive Go-to-Market (GTM) and co-sell support from Microsoft for five years. This includes marketing, sales support through Microsoft's 35,000 incentivized sellers, and technical assistance from the Microsoft AI Cloud Partner Program.
這項合作包括微軟在五年內提供的廣泛市場推廣（GTM）和聯合銷售支持。其中包括通過微軟的35,000名受激勵銷售員提供的營銷、銷售支持，以及來自微軟人工智能雲合作伙伴計劃的技術支持。
What Else: Rezolve AI's Brain Suite aims to address common eCommerce challenges such as reducing cart abandonment and improving customer engagement with AI capabilities available in 95 languages. The solutions are designed to enhance operational efficiency and provide a quick return on investment (ROI).
其他信息：Rezolve AI的Brain Suite旨在解決常見的電子商務挑戰，如減少購物車棄購率，並利用95種語言中可用的人工智能功能改善客戶參與度。這些解決方案旨在提高運營效率並實現快速的投資回報（ROI）。
RZLV And MSFT Price Action: Rezolve shares were up by 29.7% at $8.52 and Microsoft shares were up by 0.01% at $417.09 at the time of writing, according to Benzinga pro.
RZLV和MSFT股價表現：根據Benzinga Pro，Rezolve股價在撰寫時上漲了29.7%，達到8.52美元，微軟股價上漲了0.01%，達到417.09美元。
- Medicare Drug Price Negotiation Program Gets Final Guidance For Second Cycle, $1.5B Savings Expected
- 醫保藥品價格談判項目獲得第二輪最終指導，預計可節省15億美元。
Image via Unsplash.
通過Unsplash獲取圖片。